Karl Mulligan

572 total citations
12 papers, 300 citations indexed

About

Karl Mulligan is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Karl Mulligan has authored 12 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in Karl Mulligan's work include Cell Adhesion Molecules Research (3 papers), Proteoglycans and glycosaminoglycans research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Karl Mulligan is often cited by papers focused on Cell Adhesion Molecules Research (3 papers), Proteoglycans and glycosaminoglycans research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Karl Mulligan collaborates with scholars based in United Kingdom, United States and Germany. Karl Mulligan's co-authors include Patrick G. Johnston, D. McCormick, H. B. Gillespie, David Waugh, Suzanne McFarlane, D. Paul Harkin, A Hill, Allal Ouhtit, Richard D. Kennedy and Paul B. Mullan and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Karl Mulligan

11 papers receiving 292 citations

Peers

Countries citing papers authored by Karl Mulligan

Since Specialization

Citations

This map shows the geographic impact of Karl Mulligan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Mulligan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Mulligan more than expected).

Fields of papers citing papers by Karl Mulligan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Mulligan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Mulligan. The network helps show where Karl Mulligan may publish in the future.

Co-authorship network of co-authors of Karl Mulligan

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Mulligan. A scholar is included among the top collaborators of Karl Mulligan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Mulligan. Karl Mulligan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Harnessing nucleotide metabolism and immunity in cancer: a tumour microenvironment perspective 2024 ·FEBS Journal ·Hani Suleiman, (unknown), Peter M. Wilson, Karl Mulligan, Robert D. Ladner, Melissa J. LaBonte	5
2	Targeting nucleotide metabolism enhances the efficacy of anthracyclines and anti-metabolites in triple-negative breast cancer 2021 ·npj Breast Cancer ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Vivien E. Prise, Kienan I. Savage, Richard H. Wilson, Karl Mulligan, Peter M. Wilson, Robert D. Ladner, Melissa J. LaBonte	15
3	Structure Here, Bias There: Hierarchical Generalization by Jointly Learning Syntactic Transformations 2021 ·University of Massachusetts (UMass) Amherst ·Karl Mulligan, Robert Frank, Tal Linzen	2
4	Grounded Sequence to Sequence Transduction 2020 ·IEEE Journal of Selected Topics in Signal Processing ·Lucia Specia, Loïc Barrault, Ozan Çağlayan, Amanda Duarte, Desmond Elliott, Spandana Gella, (unknown), (unknown), (unknown), Jindřich Libovický, Pranava Madhyastha, Florian Metze, Karl Mulligan, (unknown), Shruti Palaskar, Ramon Sanabria, Josiah Wang, Raman Arora	2
5	TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities. 2014 ·Oncotarget ·Zenobia D’Costa, Catherine Higgins, Chee Wee Ong, Gareth Irwin, David S. Boyle, Darragh G. McArt, Karen D. McCloskey, Niamh E. Buckley, Nyree Crawford, (unknown), James T. Murray, Richard D. Kennedy, Karl Mulligan, (unknown), David Waugh, Christopher J. Scott, Manuel Salto‐Tellez, Richard D. Williams, Paul B. Mullan	36
6	Generation of a non-small cell lung cancer transcriptome microarray 2008 ·BMC Medical Genomics ·(unknown), Gavin R. Oliver, Vadim Farztdinov, Richard D. Kennedy, Jude M. Mulligan, (unknown), Susan Farragher, John K. Field, Patrick G. Johnston, D. Paul Harkin, Vitali Proutski, Karl Mulligan	18
7	Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells 2006 ·Oncogene ·A Hill, Suzanne McFarlane, Karl Mulligan, H. B. Gillespie, (unknown), (unknown), Allal Ouhtit, Patrick G. Johnston, D. Paul Harkin, D. McCormick, David Waugh	106
8	A genetic signature of relapse in stage II colorectal cancer derived from formalin fixed paraffin embedded tissue (FFPE) tissue using a unique disease specific colorectal array 2006 ·Journal of Clinical Oncology ·P. G. Johnston, Karl Mulligan, E. Kay, (unknown), Stephen D. Moore, (unknown), R Wilson, Denis W. Harkin	13
9	BRCA1 and c-Myc Associate to Transcriptionally Repress Psoriasin, a DNA Damage–Inducible Gene 2005 ·Cancer Research ·Richard D. Kennedy, Julia J. Gorski, Jennifer E. Quinn, Gail E. Stewart, Colin R. James, (unknown), Karl Mulligan, Ethan Emberley, T F Lioe, Patrick J. Morrison, Paul B. Mullan, George Reid, Patrick G. Johnston, Peter H. Watson, D. Paul Harkin	71
10	Characterization of a novel oncofetal cell surface glycoprotein 2002 ·Neuropathology and Applied Neurobiology ·Karl Mulligan, H. B. Gillespie, M. Mirakhur, D. McCormick	0
11	Epidermal growth factor up-regulates CD44-dependent astrocytoma invasionin vitro 2000 ·The Journal of Pathology ·(unknown), Karl Mulligan, H. B. Gillespie, (unknown), Paul C. Winter, Patrick G. Johnston, D. McCormick	31
12	Epidermal growth factor up‐regulates CD44‐dependent astrocytoma invasion in vitro 2000 ·The Journal of Pathology ·(unknown), Karl Mulligan, H. B. Gillespie, (unknown), Paul C. Winter, Patrick G. Johnston, D. McCormick	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact